Pacaldo, Riza V.
HRN: 27-39-30 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
CEFUROXIME 1.5GM (VIAL)
08/09/2025
08/09/2025
IV
1.5g
Once
For OR
Checking Initial Appropriateness
08/09/2025
CEFUROXIME 1.5GM (VIAL)
08/09/2025
08/10/2025
IV
1.5gm
Q8
S/p Cs
Checking Initial Appropriateness
08/10/2025
CEFUROXIME 500MG (TAB)
08/10/2025
08/16/2025
PO
500mg
Bid
Cs
Checking Initial Appropriateness